BIO-RAD LABORATORIES, INC. manufactures and supplies to life sciences research, healthcare, analytical chemistry, semiconductor and other markets a broad range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components.
| Revenue (Most Recent Fiscal Year) | $2.58B |
| Net Income (Most Recent Fiscal Year) | $759.90M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | 32.81 |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 3.14 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 1.19 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 30.35 |
| Pre-Tax Margin (Trailing 12 Months) | 8.58% |
| Net Margin (Trailing 12 Months) | 6.52% |
| Return on Equity (Trailing 12 Months) | 3.56% |
| Return on Assets (Trailing 12 Months) | 2.49% |
| Current Ratio (Most Recent Fiscal Quarter) | 3.21 |
| Quick Ratio (Most Recent Fiscal Quarter) | 2.37 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.12 |
| Inventory Turnover (Trailing 12 Months) | 1.61 |
| Book Value per Share (Most Recent Fiscal Quarter) | $276.16 |
| Earnings per Share (Most Recent Fiscal Quarter) | -- |
| Earnings per Share (Most Recent Fiscal Year) | -- |
| Diluted Earnings per Share (Trailing 12 Months) | $6.07 |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Medical Devices |
| Common Shares Outstanding | 26.76M |
| Free Float | 19.17M |
| Market Capitalization | $8.14B |
| Average Volume (Last 20 Days) | 237.45 |
| Beta (Past 60 Months) | 0.95 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 28.38% |
| Percentage Held By Institutions (Latest 13F Reports) | 0.01% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |